Literature DB >> 17607123

No association between TGFBR1*6A and lung cancer.

Weiming You1, Zeyi Liu, Jun Zhao, Mingfeng Zheng, Shi-Ying Zheng, Xia Liu, Hong-Tao Zhang.   

Abstract

INTRODUCTION: TGFBR1*6A, a functionally polymorphic allele in the transforming growth factor [beta] receptor 1 gene (TGFBR1), has been hypothesized to increase risk of various cancers. However, little has been documented about connection of this variant with lung cancer.
METHODS: In an attempt to explore whether the TGFBR1*6A is associated with lung cancer, we performed genotyping followed by sequencing in 252 patients with lung cancer and 250 healthy controls.
RESULTS: The frequency for the heterozygote 9A/6A is 13.9% in cases compared with 12.4% in controls, and the odds ratio is 1.14 (95% confidence interval: 0.68-1.91), which is not statistically significant (p = 0.62), suggesting that TGFBR1*6A could not be a cancer susceptibility factor for Chinese patients with lung cancer.
CONCLUSIONS: We have no evidence to support the hypothesis that TGFBR1*6A is associated with lung cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17607123     DOI: 10.1097/JTO.0b013e318070ccd7

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  11 in total

1.  Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer.

Authors:  Moubin Lin; David J Stewart; Margaret R Spitz; Michelle A T Hildebrandt; Charles Lu; Jie Lin; Jian Gu; Maosheng Huang; Scott M Lippman; Xifeng Wu
Journal:  Carcinogenesis       Date:  2011-04-22       Impact factor: 4.944

2.  Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.

Authors:  Wei Guo; Zhiming Dong; Yanli Guo; Zhifeng Chen; Zhibin Yang; Gang Kuang
Journal:  Mol Biol Rep       Date:  2011-07-22       Impact factor: 2.316

3.  Debate about TGFBR1 and the susceptibility to colorectal cancer.

Authors:  Laura Valle
Journal:  World J Gastrointest Oncol       Date:  2012-01-15

Review 4.  TGFBR1 signaling and breast cancer.

Authors:  Lakisha Moore-Smith; Boris Pasche
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-04-05       Impact factor: 2.673

5.  Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study.

Authors:  Yun-Sheng Hu; Yong Pan; Wen-Hai Li; Yong Zhang; Jun Li; Bao-An Ma
Journal:  BMC Cancer       Date:  2010-04-29       Impact factor: 4.430

6.  TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.

Authors:  Ru-Yan Liao; Chen Mao; Li-Xin Qiu; Hong Ding; Qing Chen; Hai-Feng Pan
Journal:  Mol Biol Rep       Date:  2009-11-01       Impact factor: 2.316

7.  TGFBR1 haplotypes and risk of non-small-cell lung cancer.

Authors:  Zhe Lei; Reng-Yun Liu; Jun Zhao; Zeyi Liu; Xiefang Jiang; Weiming You; Xiao-Feng Chen; Xia Liu; Kui Zhang; Boris Pasche; Hong-Tao Zhang
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

8.  Colorectal cancers in patients with the (9A/6A) polymorphism of TGFBR1 exhibit lesser inter-(simple sequence repeat) PCR genomic instability and present clinically at greater age.

Authors:  Smitha S Dutt; Neng Chen; Huferesh K Darbary; Helen Swede; Nicholas J Petrelli; Daniel L Stoler; Garth R Anderson
Journal:  Mutat Res       Date:  2008-08-20       Impact factor: 2.433

9.  The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.

Authors:  Adela Castillejo; Trinidad Mata-Balaguer; Paola Montenegro; Enrique Ochoa; Rafael Lázaro; Ana Martínez-Cantó; María-Isabel Castillejo; Carla Guarinos; Víctor-Manuel Barberá; Carmen Guillén-Ponce; Alfredo Carrato; José-Luís Soto
Journal:  BMC Cancer       Date:  2009-06-18       Impact factor: 4.430

Review 10.  Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies.

Authors:  Yong-qiang Wang; Xiao-wei Qi; Fan Wang; Jun Jiang; Qiao-nan Guo
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.